Defining "value" to various stakeholders...
Should we define value based on quality arguments from the general public? After all, we are the ones funding the services that we are seeking. How about patients? There are many unique nuances that are difficult to anticipate unless you have truly experienced a diagnosis or underwent treatment. Could this lead to bias? Do we lack the understanding of downstream outcomes beyond the treatment seeking episode of care? What about the healthcare provider? Certainly all of the medical and scientific knowledge should inform what should be considered a positive outcome. We have learned that the patient needs a voice but how and when should we integrate patient centricity in the cycle of care? What about the decision makers such as the CMS, insurance industry, FDA, or governance of healthcare law?
I am sure you can imagine how these perspectives can be influenced by what specific lens you choose to evaluate care decisions.
- Objective vs. subjective measures
- Condition specific vs. generic measures
- Clinician (or proxy) vs. patient reported measures
- Health related quality of life vs. overall well-being measures
Let's begin having these discussions...